U.S. patent appeal board ruled against University of California in CRISPR interference
On Mar. 1, 2022, the Patent and Trial Appeal Board of the U.S .Patent and Trademark Office issued…
CDC reported effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19 among children and adolescents
On Mar. 1, 2022, the CDC reported that Two doses of Pfizer-BioNTech vaccine protect against COVID-19ﾖassociated emergency department…
Possible case of deer-to-human SARS-CoV-2 transmission
On Feb. 25, 2022, researchers announced that wildlife reservoirs of SARS-CoV-2 can lead to viral adaptation and spillback…
EMA’s Committee for Medicinal Products for Human Use recommended authorization of Covid-19 vaccine in children (6-11 Years) In the EU
On Feb. 24, 2022, Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
USDA confirmed highly pathogenic Avian influenza in a non-commercial backyard flock in Michigan
On Feb. 24, 2022, the U.S. Department of Agricultureﾒs Animal and Plant Health Inspection Service confirmed the presence…
Novavax announced extended durability of protection against infection and disease in UK COVID-19 vaccine phase 3 clinical Trial
On Feb. 24, 2022, Novavax shared extended analysis from its pivotal Phase 3 clinical trial conducted in the…
CDC’s ACIP issued recommendation for use of Moderna COVID-19 vaccine in adults aged =18 years
On Feb. 24, 2022, the Advisory Committee on Immunization Practices (ACIP) issued a standard recommendation for use of…
University of Oxford researchers created largest ever human family tree
On Feb. 24, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
Sanofi and GSK announced regulatory authorization for COVID-19 vaccine
On Feb. 23, 2022, Sanofi and GSK today announce that they intend to submit data from both their…
Moderna and Thermo Fisher Scientific announced long-term strategic collaboration
On Feb. 23, 2022, Moderna and Thermo Fisher Scientific announced a 15-year strategic collaboration agreement to enable dedicated…
Novavax announced shipments of COVID-19 vaccine to European Union member states
On Feb. 23, 2022, Novavax announced the first doses of Nuvaxovidﾙ COVID-19 Vaccine (recombinant, adjuvanted) had begun shipping…
Published study detailed proof-of-concept for COVID-19 detection via saliva screening
On Feb. 23, 2022, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
USDA confirmed highly pathogenic Avian influenza in a commercial poultry flock in Delaware
On Feb. 23, 2022, the U.S. Department of Agricultureﾒs Animal and Plant Health Inspection Service confirmed the presence…
USDA confirmed highly pathogenic avian influenza in non-commercial backyard flock in New York
On Feb. 22, 2022, the U.S. Department of Agricultureﾒs Animal and Plant Health Inspection Service confirmed the presence…
Moderna expanded global footprint through commercial partnership with Adium in Latin America
On Feb. 22, 2022, Moderna announced a distribution service agreement with Adium Pharma, a leading private Latin American…
Novavax and Serum Institute of India announced first EUA of COVID-19 vaccine in adolescents =12 to <18 in India
On Mar. 22, 2022, Novavax and Serum Institute of India announced that the Drugs Controller General of India…
University of Oxford researchers created largest ever human family tree
On Jan. 24, 2022, researchers from the University of Oxfordﾒs Big Data Institute announced a major step towards…
USDA confirmed highly pathogenic avian influenza in non-commercial backyard flock in New York
On Feb. 19, 2022, the U.S. Department of Agricultureﾒs Animal and Plant Health Inspection Service (APHIS) confirmed the…
WHO announced first technology recipients of mRNA vaccine hub
On Feb. 18, 2022, the WHO announced the first six countries that will receive the technology needed to…
CDC released the 2022 recommended immunization schedules for children and adolescents, as well as for adults
On Feb. 18, 2022, the CDC released the 2022 recommended immunization schedules for ages 19 years or older….
Health Canada authorized Novavax COVID-19 vaccine
On Feb. 17, 2022, Novavax announced that Health Canada had granted authorization for Nuvaxovidﾙ COVID-19 Vaccine (Recombinant protein,…
Scientists pinpointed mechanisms associated with severe COVID-19 blood clotting
On Feb. 17, 2022, after studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers,…
Resverlogix expanded phase 2b clinical trial for COVID-19 treatment with first site in Brazil and second in Canada
On Feb. 17, 2022, Resverlogix announced that the first Brazilian site had been initiated for its Phase 2b…
BioNTech introduced first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
On Feb. 16, 2022, BioNTech announced it had introduced its approach to establishing scalable vaccine production by developing…
In a first for imaging, new microscope captured details, 3D motion of molecules in liquid
On Feb. 16, 2022, the McKelvey School of Engineering at Washington University in St. Louis, announced that it…
USDA confirmed highly pathogenic Avian influenza in flock of chickens in Kentucky and backyard flock in Virginia
On Feb. 14, 2022, the U.S. Department of Agricultureﾒs (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
CDC announced H5N1 bird flu virus in U.S. wild birds and poultry posed a low risk to the public
On Feb. 14, 2022, CDC reported that the current risk to the general publicﾒs health from HPAI A(H5N1)…
China approved use of Pfizer’s COVID drug Paxlovid
On Feb. 12, 2022, China’s medical products regulator announced that it had given conditional approval for Pfizer’s (PFE.N)…
Pfizer and BioNTech updated rolling submission for EUA of COVID-19 caccine in children 6 months through 4 years of Age
On Feb. 11, 2022, Pfizer and BioNTech announced plans to extend their rolling submission to the U.S. Food…
WHO granted prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
On Feb. 11, 2022, Roche announced that Actemraﾮ/RoActemraﾮ (tocilizumab) intravenous (IV) had been granted World Health Organization (WHO)…